RESUMO
Objective To explore the application of continuing nursing model in life of puerperae with preterm infants and evaluate its effects.Methods Based on continuous nursing model of Ahmadi,puerperae's continuing nursing program was constructed.Randomized controlled trail design was used,and totally 110 puerperae in a hospital in Beijing were recruited from August 2016 to March 2017.The experimental group received continuing nursing intervention model,and the control group received routine nursing care.Parenting knowledge and psychological evaluation of the two groups were collected 3 days before discharge,1 month,3 months and 6 months after discharge.Results Ninety-eight puerperae completed the study.In the experimental group,the score of parenting knowledge was higher than that of the control group(P＜0.01),and the total score of mental health assessment and scores of depression and anxiety were lower than those in the control group (P＜0.05).Conclusion Puerperae's continuing nursing program based on the continuous nursing model of Ahmadi improved maternal ability and positive emotion,and promoted quality of life.
RESUMO
In order to determine the optimum extracting process of the isoflavone from Dabie Mountain's Pueraria lobata and its reducing power, a 5-level, 4-factor Box-Behnken center-united experiment was conducted on the basis of single factor experiment. The Box-Behnken experiment analyzed and optimized the processing conditions by response surface methodology, and determined the reducing power of the Pueraria Isoflavone's extract under the optimum conditions. The results showed that the extraction rate of the Pueraria Isoflavone was 24.87%, of which the relative error was only 0.4% compared with the predicted value of 24.77%, under the optimum conditions of ethanol concentration 7.5%, liquid-to-solid ratio17.50 mL/g, treatment temperature 94.30°C, treatment time 47.36 min. The experiment also concluded that response surface methodology was suitable for the regression analysis of isoflavone's extraction rate and parameter optimization; the reducing power of Pueraria Isoflavone's EC50 value was 0.098 mg/mL.
